Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Talatisamine (12 μM) and TEA (5mM) inhibits the enhanced I(K) caused by Aβ4 oligomers, attenuates cytotoxicity of Aβ oligomers by restoring cell viability and suppressing K(+) loss related apoptotic response. 2. Talatisamine can therefore be considered as a leading compound worthy of further investigations.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 13,500 | |||
5 mg | 在庫あり | ¥ 30,000 | |||
10 mg | 在庫あり | ¥ 50,500 | |||
25 mg | 在庫あり | ¥ 88,500 | |||
50 mg | 在庫あり | ¥ 127,000 | |||
100 mg | 在庫あり | ¥ 192,000 |
説明 | 1. Talatisamine (12 μM) and TEA (5mM) inhibits the enhanced I(K) caused by Aβ4 oligomers, attenuates cytotoxicity of Aβ oligomers by restoring cell viability and suppressing K(+) loss related apoptotic response. 2. Talatisamine can therefore be considered as a leading compound worthy of further investigations. |
ターゲット&IC50 | IK channel:146 μM |
植物由来 |
分子量 | 421.57 |
分子式 | C24H39NO5 |
CAS No. | 20501-56-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 32 mg/mL(75.9 mM)
Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Talatisamine 20501-56-8 Membrane transporter/Ion channel Potassium Channel KcsA Inhibitor Alzheimer's neurotoxicity inhibit disease inhibitor